High fatty acids modulate P2X7 expression and IL-6 release via the p38 MAPK pathway in PC12 cells

Brain Research Bulletin

Volumn 94, Issue , 2013, Pages 63-70

  Xu, Hong ^a   Wu, Bing ^a   Jiang, Fuqing ^a   Xiong, Shaoheng ^a   Zhang, Baoping ^a   Li, Guilin ^a   Liu, Shuangmei ^a   Gao, Yun ^a   Xu, Changshui ^a   Tu, Guihua ^a   Peng, Haiying ^a   Liang, Shangdong ^a   Xiong, Huangui ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Diabetic neuropathy; High fatty acids; P2X7 receptor; P38; PC12

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE TRIPHOSPHATE; FATTY ACID; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PURINERGIC P2X7 RECEPTOR; SMALL INTERFERING RNA;

ARTICLE; CALCIUM SIGNALING; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; PC12 CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; FATTY ACIDS; FLUORESCENT ANTIBODY TECHNIQUE; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; PC12 CELLS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P2X7; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84875620255     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.02.002     Document Type: Article

References (53)

1. Adinolfi E., Callegari M.G., Ferrari D., Bolognesi C., Minelli M., Wieckowski M.R., Pinton P., Rizzuto R., Di Virgilio F. Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Molecular Biology of the Cell 2005, 16:3260-3272.
2. Al-Ani F.S., Al-Nimer M.S., Ali F.S. Dyslipidemia as a contributory factor in etiopathogenesis of diabetic neuropathy. Indian Journal of Endocrinology and Metabolism 2011, 15:110-114.
3. Andó R.D., Sperlágh B. The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain. Brain Research Bulletin 2012, pii: S0361-9230(12)00216-X [Epub ahead of print]. 10.1016/j.brainresbull.2012.09.016.
4. Armstrong J.N., Brust T.B., Lewis R.G., MacVicar B.A. Activation of presynaptic P2X7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase. Journal of Neuroscience 2002, 22:5938-5945.
5. Boden G., Chen X., Ruiz J., White J.V., Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. Journal of Clinical Investigation 1994, 93:2438-2446.
6. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiological Reviews 2007, 87:659-797.
7. Burnstock G., Krugel U., Abbracchio M.P., Illes P. Purinergic signalling: from normal behaviour to pathological brain function. Progress in Neurobiology 2011, 95:229-274.
8. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:10061-10065.
9. Chappey O., Dosquet C., Wautier M.P., Wautier J.L. Advanced glycation end products, oxidant stress and vascular lesions. European Journal of Clinical Investigation 1997, 27:97-108.
10. Correa S.A., Eales K.L. The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease. Journal of Signal Transduction 2012, 2012:649079.
11. Di Virgilio F., Ferrari D., Adinolfi E. P2X(7): a growth-promoting receptor-implications for cancer. Purinergic Signalling 2009, 5:251-256.
12. Diakogiannaki E., Welters H.J., Morgan N.G. Differential regulation of the endoplasmic reticulum stress response in pancreatic beta-cells exposed to long-chain saturated and monounsaturated fatty acids. Journal of Endocrinology 2008, 197:553-563.
13. Friedle S.A., Brautigam V.M., Nikodemova M., Wright M.L., Watters J.J. The P2X7-Egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia. Glia 2011, 59:1-13.
14. Gadegbeku C.A., Shrayyef M.Z., Taylor T.P., Egan B.M. Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension. Journal of Hypertension 2006, 24:1383-1389.
15. Gadient R.A., Otten U. Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neuroscience Letters 1994, 182:243-246.
16. Glas R., Sauter N.S., Schulthess F.T., Shu L., Oberholzer J., Maedler K. Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival. Diabetologia 2009, 52:1579-1588.
17. Hirose H., Lee Y.H., Inman L.R., Nagasawa Y., Johnson J.H., Unger R.H. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. Journal of Biological Chemistry 1996, 271:5633-5637.
18. Juttler E., Tarabin V., Schwaninger M. Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity. Neuroscientist 2002, 8:268-275.
19. Klein M.A., Moller J.C., Jones L.L., Bluethmann H., Kreutzberg G.W., Raivich G. Impaired neuroglial activation in interleukin-6 deficient mice. Glia 1997, 19:227-233.
20. Li G.L., Xu H., Zhu S.H., Xu W.Y., Qin S.L., Liu S.M., Tu G.H., Peng H.Y., Qiu S.Y., Yu S.C., Zhu Q.C., Fan B., Zheng C.R., Li G.D., Liang S.D. Effects of neferine on CCL5 and CCR5 expression in SCG of type 2 diabetic rats. Brain Research Bulletin 2013, 90:79-87.
21. Lister M.F., Sharkey J., Sawatzky D.A., Hodgkiss J.P., Davidson D.J., Rossi A.G., Finlayson K. The role of the purinergic P2X7 receptor in inflammation. Journal of Inflammation (London) 2007, 4:1-14.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
23. Loddick S.A., Turnbull A.V., Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. Journal of Cerebral Blood Flow and Metabolism 1998, 18:176-179.
24. Ma S.H., Li B., Huang H.W., Peng Y.P., Qiu Y.H. Interleukin-6 inhibits L-type calcium channel activity of cultured cerebellar granule neurons. Journal of Physiological Sciences 2012, 62:385-392.
25. Manzella D., Barbieri M., Rizzo M.R., Ragno E., Passariello N., Gambardella A., Marfella R., Giugliano D., Paolisso G. Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. Journal of Clinical Endocrinology and Metabolism 2001, 86:2769-2774.
26. Marz P., Cheng J.G., Gadient R.A., Patterson P.H., Stoyan T., Otten U., Rose-John S. Sympathetic neurons can produce and respond to interleukin 6. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:3251-3256.
27. Murphy P.G., Grondin J., Altares M., Richardson P.M. Induction of interleukin-6 in axotomized sensory neurons. Journal of Neuroscience 1995, 15:5130-5138.
28. Nakamachi T., Tsuchida M., Kagami N., Yofu S., Wada Y., Hori M., Tsuchikawa D., Yoshikawa A., Imai N., Nakamura K., et al. IL-6 and PACAP receptor expression and localization after global brain ischemia in mice. Journal of Molecular Neuroscience 2012, 48:518-525.
29. Nelson T.E., Olde E.A., Hernandez R., Puro A., Huitron-Resendiz S., Hao C., De Graan P.N., Gruol D.L. Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6. Brain, Behavior, and Immunity 2012, 26:959-971.
30. North R.A. Molecular physiology of P2X receptors. Physiological Reviews 2002, 82:1013-1067.
31. Oliver M.F., Opie L.H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994, 343:155-158.
32. Orellana D.I., Quintanilla R.A., Gonzalez-Billault C., Maccioni R.B. Role of the JAKs/STATs pathway in the intracellular calcium changes induced by interleukin-6 in hippocampal neurons. Neurotoxicity Research 2005, 8:295-304.
33. Paolisso G., Manzella D., Rizzo M.R., Ragno E., Barbieri M., Varricchio G., Varricchio M. Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects. American Journal of Clinical Nutrition 2000, 72:723-730.
34. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacological Reviews 1998, 50:413-492.
35. Russell J.W., Feldman E.L. Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose. Hormone and Metabolic Research 1999, 31:90-96.
36. Russell J.W., Sullivan K.A., Windebank A.J., Herrmann D.N., Feldman E.L. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiology of Disease 1999, 6:347-363.
37. Sabin M.A., Stewart C.E., Crowne E.C., Turner S.J., Hunt L.P., Welsh G.I., Grohmann M.J., Holly J.M., Shield J.P. Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid. Journal of Cellular Physiology 2007, 211:244-252.
38. Selzner N., Selzner M., Graf R., Ungethuem U., Fitz J.G., Clavien P.A. Water induces autocrine stimulation of tumor cell killing through ATP release and P2 receptor binding. Cell Death and Differentiation 2004, 11(Suppl. 2):S172L 180.
39. Shafer T.J., Atchison W.D. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology 1991, 12:473-492.
40. Smith A.G., Singleton J.R. Diabetic neuropathy. Continuum (Minneap Minn) 2012, 18:60-84.
41. Smith J.A., Das A., Ray S.K., Banik N.L. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Research Bulletin 2012, 87(1):10-20.
42. Solini A., Chiozzi P., Falzoni S., Morelli A., Fellin R., Di Virgilio F. High glucose modulates P2X7 receptor-mediated function in human primary fibroblasts. Diabetologia 2000, 43:1248-1256.
43. Solini A., Chiozzi P., Morelli A., Adinolfi E., Rizzo R., Baricordi O.R., Di Virgilio F. Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology 2004, 24:1240-1245.
44. Stepniakowski K.T., Goodfriend T.L., Egan B.M. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension 1995, 25:774-778.
45. Tang Y., Li G.D. Chronic exposure to high glucose impairs bradykinin-stimulated nitric oxide production by interfering with the phospholipase-C-implicated signalling pathway in endothelial cells: evidence for the involvement of protein kinase C. Diabetologia 2004, 47:2093-2104.
46. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995, 44:863-870.
47. Vincent A.M., Hayes J.M., McLean L.L., Vivekanandan-Giri A., Pennathur S., Feldman E.L. Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 2009, 58:2376-2385.
48. Vincent A.M., Hinder L.M., Pop-Busui R., Feldman E.L. Hyperlipidemia: a new therapeutic target for diabetic neuropathy. Journal of the Peripheral Nervous System 2009, 14:257-267.
49. Vizi E.S., Sperlagh B., Baranyi M. Evidence that ATP released from the postsynaptic site by noradrenaline, is involved in mechanical responses of guinea-pig vas deferens: cascade transmission. Neuroscience 1992, 50:455-465.
50. Vizi E.S., Liang S.D., Sperlagh B., Kittel A., Juranyi Z. Studies on the release and extracellular metabolism of endogenous ATP in rat superior cervical ganglion: support for neurotransmitter role of ATP. Neuroscience 1997, 79:893-903.
51. Volonte C., Apolloni S., Skaper S.D., Burnstock G. P2X7 receptors: channels, pores and more. CNS & Neurological Disorders - Drug Targets 2012, 11:705-721.
52. Vonend O., Turner C.M., Chan C.M., Loesch A., Dell'Anna G.C., Srai K.S., Burnstock G., Unwin R.J. Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. Kidney International 2004, 66:157-166.
53. Yang P., Wen H., Ou S., Cui J., Fan D. IL-6 promotes regeneration and functional recovery after cortical spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation. Experimental Neurology 2012, 236:19-27.